Rikeshwer Prasad Dewangan

Employment

• Jamia Hamdard Assistant Professor
  2019 - Present
• Ben-Gurion University of the Negev Postdoctoral Fellow
  2018 - 2019
• Central Drug Research Institute SERB-National Postdoctoral Fellowship
  2017 - 2018
• Institute of Genomics and Integrative Biology CSIR PhD student
  2011 - 2017

Education

• Jamia Hamdard Faculty of Pharmacy PhD
  2013 - 2017
• Indian Institute of Technology BHU Varanasi M. Pharm. (Pharmaceutical Chemistry)
  2009 - 2011
• Guru Ghasidas University B. Pharm.
  2006 - 2009

Projects & Funding

Projects & funding information is unavailable.

Publications (41)

• Design and synthesis of a proline-arginine rich hybrid peptides against ESKAPE pathogens by inhibiting bacterial protein synthesis and DNA replication
  2026 DOI: 10.2139/ssrn.6222002
  +Save
• Spermine conjugates of non-steroidal anti-inflammatory drugs as potent antibacterials against multidrug-resistant S. aureus and Enterococcus sp.
  European Journal of Medicinal Chemistry 2026 DOI: 10.1016/j.ejmech.2026.119181
  +Save
• Fmoc-amino acid conjugated self-assembling gemcitabine nanoparticles against cancers with enhanced pharmacokinetic profile
  Journal of Drug Delivery Science and Technology 2025 DOI: 10.1016/j.jddst.2025.107316
  +Save
• In-Situ Synthesis of Silver Nanoparticle within Self-Assembling Ultrashort Peptide Hydrogel as Antibacterial with Wound Healing Properties
  Current Protein & Peptide Science 2025 DOI: 10.2174/0113892037367553250327084808
  +Save
• Non-steroidal anti-inflammatory drugs conjugated ultra-short Peptidomimetics as potent Antibacterials against methicillin resistant S. aureus with anti-inflammatory activity
  Bioorganic Chemistry 2025 DOI: 10.1016/j.bioorg.2025.109018
  +Save
• Pre‐column Derivatization and Ultra‐High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry‐based Method Development of Gemcitabine in Reversed‐Phase Column for Pharmaceutical Applications
  SEPARATION SCIENCE PLUS 2025 DOI: 10.1002/sscp.70139
  +Save
• Identification of novel thiazole derivatives as flaviviral protease inhibitors effective against Dengue (DENV2) and Japanese encephalitis viruses
  Antimicrobial Agents and Chemotherapy 2025 DOI: 10.1128/aac.01651-24
  +Save
• Recent Development of Zolmitriptan Formulation in Migraine Therapy: Production, Metabolism and Pharmaceutical Aspects
  CNS & Neurological Disorders - Drug Targets 2025 DOI: 10.2174/0118715273306929240820071521
  +Save
• Fabrication and Evaluation of Hyaluronic Acid Coated Albumin Nanoparticles for Delivery of Gemcitabine
  Current Drug Delivery 2025 DOI: 10.2174/0115672018317615240926163652
  +Save
• Hydrocarbon stapled temporin-L analogue as potential antibacterial and antiendotoxin agents with enhanced protease stability
  Bioorganic Chemistry 2024 DOI: 10.1016/j.bioorg.2024.107239
  +Save